Biomarin Pharmaceutical Inc (BMRN) — Working Capital to Net Assets Ratio

Latest as of December 2025: 52.5%

Biomarin Pharmaceutical Inc (BMRN) has a Working Capital to Net Assets ratio of 52.5% as of December 2025. Working capital of $3.19 Billion (current assets of $3.95 Billion minus current liabilities of $759.03 Million) is measured against net assets of $6.09 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See BMRN equity financing ratio to measure how much of total assets are equity-financed.

WC/NA Ratio

52.5%
Working Capital / Net Assets

Working Capital

$3.19 Billion
USD

Current Assets

$3.95 Billion
USD

Current Liabilities

$759.03 Million
USD

Biomarin Pharmaceutical Inc Working Capital to Net Assets (1998–2025)

This chart shows how Biomarin Pharmaceutical Inc's Working Capital to Net Assets ratio has evolved across 28 annual periods from 1998 to 2025. As of December 2025, the ratio stands at 52.5%, reflecting working capital of $3.19 Billion against net assets of $6.09 Billion USD. Check Biomarin Pharmaceutical Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Biomarin Pharmaceutical Inc (1998–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BMRN market cap overview.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 52.5% $3.19 Billion $6.09 Billion $3.95 Billion $759.03 Million ▲ +6.1 pp
2024 46.4% $2.63 Billion $5.66 Billion $3.23 Billion $606.99 Million ▲ +10.5 pp
2023 35.9% $1.78 Billion $4.95 Billion $2.96 Billion $1.18 Billion ▼ -11.1 pp
2022 47.0% $2.16 Billion $4.60 Billion $2.75 Billion $588.88 Million ▲ +6.4 pp
2021 40.6% $1.73 Billion $4.27 Billion $2.27 Billion $539.82 Million ▼ -4.4 pp
2020 45.0% $1.85 Billion $4.11 Billion $2.34 Billion $492.55 Million ▲ +12.7 pp
2019 32.3% $1.01 Billion $3.12 Billion $1.94 Billion $932.50 Million ▼ -19.3 pp
2018 51.7% $1.53 Billion $2.97 Billion $2.06 Billion $523.24 Million ▲ +2.1 pp
2017 49.5% $1.39 Billion $2.81 Billion $2.21 Billion $816.52 Million ▲ +14.0 pp
2016 35.5% $982.48 Million $2.77 Billion $1.42 Billion $439.31 Million ▲ +8.7 pp
2015 26.8% $644.18 Million $2.40 Billion $1.09 Billion $445.46 Million ▼ -51.0 pp
2014 77.9% $1.19 Billion $1.53 Billion $1.43 Billion $235.74 Million ▲ +6.7 pp
2013 71.1% $954.15 Million $1.34 Billion $1.14 Billion $183.27 Million ▲ +14.7 pp
2012 56.4% $573.03 Million $1.02 Billion $743.46 Million $170.43 Million ▲ +7.8 pp
2011 48.6% $375.68 Million $773.05 Million $469.80 Million $94.12 Million ▼ -10.0 pp
2010 58.6% $420.42 Million $717.26 Million $504.26 Million $83.84 Million ▼ -62.3 pp
2009 120.9% $389.57 Million $322.19 Million $467.73 Million $78.15 Million ▼ -98.7 pp
2008 219.6% $607.62 Million $276.68 Million $737.70 Million $130.08 Million ▼ -90.8 pp
2007 310.4% $582.75 Million $187.73 Million $644.30 Million $61.54 Million ▲ +65.8 pp
2006 244.6% $288.18 Million $117.80 Million $334.22 Million $46.05 Million ▲ +281.5 pp
2005 -36.9% $28.57 Million $-77.46 Million $68.94 Million $40.37 Million ▼ -14.5 pp
2004 -22.4% $15.22 Million $-67.98 Million $85.28 Million $70.05 Million ▼ -202.7 pp
2003 180.3% $212.45 Million $117.85 Million $225.27 Million $12.81 Million ▲ +104.9 pp
2002 75.3% $74.22 Million $98.54 Million $81.07 Million $6.85 Million ▼ -5.2 pp
2001 80.5% $128.48 Million $159.55 Million $136.78 Million $8.30 Million ▲ +26.7 pp
2000 53.8% $37.66 Million $69.99 Million $44.54 Million $6.88 Million ▼ -8.5 pp
1999 62.3% $61.34 Million $98.38 Million $66.42 Million $5.09 Million ▲ +25.6 pp
1998 36.7% $10.80 Million $29.40 Million $12.80 Million $2.00 Million
pp = percentage points